These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28825228)

  • 1. Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.
    Fortin D; Tsang D; Ng A; Laperriere N; Hodgson DC
    J Neurooncol; 2017 Dec; 135(3):521-528. PubMed ID: 28825228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
    Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
    [No Abstract]   [Full Text] [Related]  

  • 3. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
    Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume.
    Miralbell R; Lomax A; Bortfeld T; Rouzaud M; Carrie C
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):477-84. PubMed ID: 9231669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
    Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
    Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors.
    Kahalley LS; Ris MD; Grosshans DR; Okcu MF; Paulino AC; Chintagumpala M; Moore BD; Guffey D; Minard CG; Stancel HH; Mahajan A
    J Clin Oncol; 2016 Apr; 34(10):1043-9. PubMed ID: 26811522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
    Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plan robustness in proton beam therapy of a childhood brain tumour.
    Lassen-Ramshad Y; Vestergaard A; Muren LP; Høyer M; Petersen JB
    Acta Oncol; 2011 Aug; 50(6):791-6. PubMed ID: 21767176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
    Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
    Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma.
    Winkfield KM; Niemierko A; Bussiere MR; Crowley EM; Napolitano BN; Beaudette KP; Loeffler JS; Shih HA
    Technol Cancer Res Treat; 2011 Jun; 10(3):243-51. PubMed ID: 21517130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas.
    Greenberger BA; Pulsifer MB; Ebb DH; MacDonald SM; Jones RM; Butler WE; Huang MS; Marcus KJ; Oberg JA; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1060-1068. PubMed ID: 25035209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for improved intelligence quotient using volumetric modulated arc therapy compared with conventional 3-dimensional conformal radiation for whole-ventricular radiation in children.
    Qi XS; Stinauer M; Rogers B; Madden JR; Wilkening GN; Liu AK
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1206-11. PubMed ID: 22516805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shielding implications for secondary neutrons and photons produced within the patient during IMPT.
    DeMarco J; Kupelian P; Santhanam A; Low D
    Med Phys; 2013 Jul; 40(7):071701. PubMed ID: 23822405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
    Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.
    Kahalley LS; Douglas Ris M; Mahajan A; Fatih Okcu M; Chintagumpala M; Paulino AC; Whitehead WE; Minard CG; Stancel HH; Orobio J; Xue JJ; Warren EA; Grosshans DR
    Neuro Oncol; 2019 Jun; 21(6):809-818. PubMed ID: 30753584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): a retrospective review.
    Vieira WA; Weltman E; Chen MJ; da Silva NS; Cappellano AM; Pereira LD; Gonçalves MI; Ferrigno R; Hanriot RM; Nadalin W; Odone Filho V; Petrilli AS
    Radiat Oncol; 2014 Jul; 9():158. PubMed ID: 25041714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.